Single Dose Bronchodilatory Study in Asthma

Completed · Phase 4

Conditions studied: Asthma

In brief

Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.

Key facts

Study ID

NCT01805687

Run by

Cornerstone Therapeutics Inc.

People needed

25

Starts

2013-03-01

Last updated by the study team

2014-09-03

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of asthma for at least 5 years
• FEV1 of 50-85% predicted
• Reversible airway obstruction

You may not qualify if…

• Pregnant/nursing females
• Liver function tests greater than upper limit of normal

Where it is running

• Northeast Medical Research Associates — North Dartmouth, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.